In 2013, BM-MSC infusion upregulated IL-12 levels and downregulated IL-4, IL-13, OVA-specific IgE, OVA-specific IgG1 and OVA-specific IgG2a levels in a mouse asthma model [118]. This evidence concerns the gene IL4 and asthma.